Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer

  1. Tolaney, S.M.
  2. Guarneri, V.
  3. Seo, J.H.
  4. Cruz, J.
  5. Abreu, M.H.
  6. Takahashi, M.
  7. Barrios, C.
  8. McIntyre, K.
  9. Wei, R.
  10. Munoz, M.
  11. Antonio, B.S.
  12. Liepa, A.M.
  13. Martin, M.
  14. Johnston, S.R.D.
  15. Kellokumpu-Lehtinen, P.-L.
  16. Harbeck, N.
Zeitschrift:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Datum der Publikation: 2024

Ausgabe: 199

Art: Artikel

DOI: 10.1016/J.EJCA.2024.113555 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus